Deep radiomic model based on the sphere–shell partition for predicting treatment response to chemotherapy in lung cancer

Background: The prognosis of chemotherapy is important in clinical decision-making for non-small cell lung cancer (NSCLC) patients. Objectives: To develop a model for predicting treatment response to chemotherapy in NSCLC patients from pre-chemotherapy CT images. Materials and Methods: This retrospe...

Full description

Bibliographic Details
Main Authors: Runsheng Chang, Shouliang Qi, Yanan Wu, Yong Yue, Xiaoye Zhang, Yubao Guan, Wei Qian
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Translational Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523323001055
_version_ 1797778355212255232
author Runsheng Chang
Shouliang Qi
Yanan Wu
Yong Yue
Xiaoye Zhang
Yubao Guan
Wei Qian
author_facet Runsheng Chang
Shouliang Qi
Yanan Wu
Yong Yue
Xiaoye Zhang
Yubao Guan
Wei Qian
author_sort Runsheng Chang
collection DOAJ
description Background: The prognosis of chemotherapy is important in clinical decision-making for non-small cell lung cancer (NSCLC) patients. Objectives: To develop a model for predicting treatment response to chemotherapy in NSCLC patients from pre-chemotherapy CT images. Materials and Methods: This retrospective multicenter study enrolled 485 patients with NSCLC who received chemotherapy alone as a first-line treatment. Two integrated models were developed using radiomic and deep-learning-based features. First, we partitioned pre-chemotherapy CT images into spheres and shells with different radii around the tumor (0–3, 3–6, 6–9, 9–12, 12–15 mm) containing intratumoral and peritumoral regions. Second, we extracted radiomic and deep-learning-based features from each partition. Third, using radiomic features, five sphere–shell models, one feature fusion model, and one image fusion model were developed. Finally, the model with the best performance was validated in two cohorts. Results: Among the five partitions, the model of 9–12 mm achieved the highest area under the curve (AUC) of 0.87 (95% confidence interval: 0.77–0.94). The AUC was 0.94 (0.85–0.98) for the feature fusion model and 0.91 (0.82–0.97) for the image fusion model. For the model integrating radiomic and deep-learning-based features, the AUC was 0.96 (0.88–0.99) for the feature fusion method and 0.94 (0.85–0.98) for the image fusion method. The best-performing model had an AUC of 0.91 (0.81–0.97) and 0.89 (0.79–0.93) in two validation sets, respectively. Conclusions: This integrated model can predict the response to chemotherapy in NSCLC patients and assist physicians in clinical decision-making.
first_indexed 2024-03-12T23:17:03Z
format Article
id doaj.art-13f85238cb1d421dbd620c1cc758d3a6
institution Directory Open Access Journal
issn 1936-5233
language English
last_indexed 2024-03-12T23:17:03Z
publishDate 2023-09-01
publisher Elsevier
record_format Article
series Translational Oncology
spelling doaj.art-13f85238cb1d421dbd620c1cc758d3a62023-07-17T04:07:33ZengElsevierTranslational Oncology1936-52332023-09-0135101719Deep radiomic model based on the sphere–shell partition for predicting treatment response to chemotherapy in lung cancerRunsheng Chang0Shouliang Qi1Yanan Wu2Yong Yue3Xiaoye Zhang4Yubao Guan5Wei Qian6College of Medicine and Biological Information Engineering, Northeastern University, Shenyang, ChinaCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, China; Key Laboratory of Intelligent Computing in Medical Image, Ministry of Education, Northeastern University, Shenyang, China; Corresponding author at :College of Medicine and Biological Information Engineering, Northeastern University, Shenyang, China.College of Medicine and Biological Information Engineering, Northeastern University, Shenyang, ChinaDepartment of Radiology, Shengjing Hospital of China Medical University, Shenyang, ChinaDepartment of Oncology, Shengjing Hospital of China Medical University, Shenyang, ChinaDepartment of Radiology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, ChinaBackground: The prognosis of chemotherapy is important in clinical decision-making for non-small cell lung cancer (NSCLC) patients. Objectives: To develop a model for predicting treatment response to chemotherapy in NSCLC patients from pre-chemotherapy CT images. Materials and Methods: This retrospective multicenter study enrolled 485 patients with NSCLC who received chemotherapy alone as a first-line treatment. Two integrated models were developed using radiomic and deep-learning-based features. First, we partitioned pre-chemotherapy CT images into spheres and shells with different radii around the tumor (0–3, 3–6, 6–9, 9–12, 12–15 mm) containing intratumoral and peritumoral regions. Second, we extracted radiomic and deep-learning-based features from each partition. Third, using radiomic features, five sphere–shell models, one feature fusion model, and one image fusion model were developed. Finally, the model with the best performance was validated in two cohorts. Results: Among the five partitions, the model of 9–12 mm achieved the highest area under the curve (AUC) of 0.87 (95% confidence interval: 0.77–0.94). The AUC was 0.94 (0.85–0.98) for the feature fusion model and 0.91 (0.82–0.97) for the image fusion model. For the model integrating radiomic and deep-learning-based features, the AUC was 0.96 (0.88–0.99) for the feature fusion method and 0.94 (0.85–0.98) for the image fusion method. The best-performing model had an AUC of 0.91 (0.81–0.97) and 0.89 (0.79–0.93) in two validation sets, respectively. Conclusions: This integrated model can predict the response to chemotherapy in NSCLC patients and assist physicians in clinical decision-making.http://www.sciencedirect.com/science/article/pii/S1936523323001055Non-small cell lung cancerTreatment response to chemotherapySphere–shell partitionRadiomicsDeep learning
spellingShingle Runsheng Chang
Shouliang Qi
Yanan Wu
Yong Yue
Xiaoye Zhang
Yubao Guan
Wei Qian
Deep radiomic model based on the sphere–shell partition for predicting treatment response to chemotherapy in lung cancer
Translational Oncology
Non-small cell lung cancer
Treatment response to chemotherapy
Sphere–shell partition
Radiomics
Deep learning
title Deep radiomic model based on the sphere–shell partition for predicting treatment response to chemotherapy in lung cancer
title_full Deep radiomic model based on the sphere–shell partition for predicting treatment response to chemotherapy in lung cancer
title_fullStr Deep radiomic model based on the sphere–shell partition for predicting treatment response to chemotherapy in lung cancer
title_full_unstemmed Deep radiomic model based on the sphere–shell partition for predicting treatment response to chemotherapy in lung cancer
title_short Deep radiomic model based on the sphere–shell partition for predicting treatment response to chemotherapy in lung cancer
title_sort deep radiomic model based on the sphere shell partition for predicting treatment response to chemotherapy in lung cancer
topic Non-small cell lung cancer
Treatment response to chemotherapy
Sphere–shell partition
Radiomics
Deep learning
url http://www.sciencedirect.com/science/article/pii/S1936523323001055
work_keys_str_mv AT runshengchang deepradiomicmodelbasedonthesphereshellpartitionforpredictingtreatmentresponsetochemotherapyinlungcancer
AT shouliangqi deepradiomicmodelbasedonthesphereshellpartitionforpredictingtreatmentresponsetochemotherapyinlungcancer
AT yananwu deepradiomicmodelbasedonthesphereshellpartitionforpredictingtreatmentresponsetochemotherapyinlungcancer
AT yongyue deepradiomicmodelbasedonthesphereshellpartitionforpredictingtreatmentresponsetochemotherapyinlungcancer
AT xiaoyezhang deepradiomicmodelbasedonthesphereshellpartitionforpredictingtreatmentresponsetochemotherapyinlungcancer
AT yubaoguan deepradiomicmodelbasedonthesphereshellpartitionforpredictingtreatmentresponsetochemotherapyinlungcancer
AT weiqian deepradiomicmodelbasedonthesphereshellpartitionforpredictingtreatmentresponsetochemotherapyinlungcancer